Cibc Private Wealth Group, LLC Beam Therapeutics Inc. Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 2,345 shares of BEAM stock, worth $68,028. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,345
Previous 1,254
87.0%
Holding current value
$68,028
Previous $29,000
96.55%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BEAM
# of Institutions
236Shares Held
75.2MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$238 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.84MShares$228 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$221 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.53MShares$189 Million1.52% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$140 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $2.04B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...